Evaluation of Pilot Online Binge Eating Disorder Group (BEG) in Under 18s.

Investigating the Efficacy of an Online Binge Eating Disorder Group Intervention for Under 18s

The National Institute for Clinical Excellence recommends a cognitive behavioural therapy (CBT) group intervention for binge eating disorder in under-18s. However, there is limited current research in this population. The present study sought to evaluate a CBT group intervention for binge eating disorder in under-18s.

Study Overview

• Status: Completed
• Conditions: Binge Eating Disorder

Detailed Description

Background and study aims: The National Institute for Clinical Excellence recommends a cognitive behavioural therapy (CBT) group intervention for binge eating disorder in under-18s. However, there is limited current research in this population. The present study sought to evaluate a CBT group intervention for binge eating disorder in under-18s.

Who can participate? Participants were recruited from the Coventry Warwickshire Partnership Trust's Children and Young People Eating Disorders Team (n=2).

What does the study involve: Participating in a group intervention and completing questionnaires (Eating Disorder Examination - Questionnaire (EDE-Q), Revised Children's Anxiety and Depression Scale (RCADS) Child and RCADS Parent) before the group, at the end of the group and a follow-up appointment, as well as a feedback form at the end of the group intervention.

What are the possible benefits and risks of participating:

• Benefits: Working towards recovering from binge eating disorder
• Risks: As with all therapy, there is a risk of distress due to the topics discussed. There is no more risk than any other group online therapy.

Where is the study run from: Online intervention for participants who are eligible and who are under the care of the RISE Eating Disorders Team within Coventry and Warwickshire NHS Partnership Trust.

When is the study starting and how long is it expected to run for: The study commenced on on 23rd May 2023. The group intervention ran from 20th June 2023 to 26th September 2023.

• Study Type: Observational
• Enrollment (Actual): 2

Contacts and Locations

Study Locations

• United Kingdom
  • West Midlands
    • Coventry, West Midlands, United Kingdom, CV2 1XA
      • Wood End Health Centre

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Population for study were young people (under 18) that are receiving support from the RISE Eating Disorder Team in the Coventry and Warwickshire Partnership Trust with a diagnosis of binge eating disorder.

Description

Inclusion Criteria:

• Diagnosed with Binge Eating Disorder
• Under 18 prior to the group commencing
• Spoke English fluently

Exclusion Criteria:

• If they were underweight. This was measured by percentage median body mass index (%mBMI) as recommended by the Medical Emergencies in Eating Disorders guidelines (Royal College of Psychiatrists, 2022) for under 18s. As such, individuals were excluded if %mBMI was less than 95%
• If they had any physical illness serious enough to prevent the participant from engaging fully in the group and completing the in-between session work
• If they were pregnant
• If they had an eating disorder-induced physical health state requiring regular medical intervention by the nursing team
• If they presented a mental health state requiring stabilisation prior to participating in the group intervention according the assessment team
• If they regularly used alcohol and/or drugs
• If they repeatedly self-harmed to the point of requiring additional interventions
• If they had a living situation not conducive to the start of an intervention (ongoing or upcoming changes).

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Eating Disorder Examination Questionnaire	The questionnaire is designed to assess the range, frequency and severity of behaviours associated with a diagnosis of an eating disorder.	23rd May 2023-26th September 2023

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Revised Children's Anxiety and Depression Scale (RCADS) Child	The Revised Children's Anxiety and Depression Scale (RCADS) measures the reported frequency of various symptoms of anxiety and low mood.	23rd May 2023-26th September 2023
Revised Children's Anxiety and Depression Scale (RCADS) Parent/Carer	The Revised Children's Anxiety and Depression Scale (RCADS) measures the reported frequency of various symptoms of anxiety and low mood.	23rd May 2023-26th September 2023
Feedback form	Feedback form asking questions about experience of the group and any recommendations for future groups.	23rd August 2023

Collaborators and Investigators

• Sponsor: Coventry and Warwickshire Partnership NHS Trust
• Collaborators: Birmingham Newman University

Study record dates

Study Major Dates

• Study Start (Actual): April 26, 2023
• Primary Completion (Actual): September 26, 2023
• Study Completion (Actual): September 26, 2023

Study Registration Dates

• First Submitted: November 18, 2024
• First Submitted That Met QC Criteria: November 20, 2024
• First Posted (Estimated): November 25, 2024

Study Record Updates

• Last Update Posted (Estimated): November 25, 2024
• Last Update Submitted That Met QC Criteria: November 20, 2024
• Last Verified: November 1, 2024

More Information

Terms related to this study

• Keywords: adolescent; group
• Additional Relevant MeSH Terms: Mental Disorders; Hyperphagia; Signs and Symptoms, Digestive; Bulimia; Binge-Eating Disorder; Feeding and Eating Disorders
• Other Study ID Numbers: 320293

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Due to the small population size, it does not feel appropriate to share the data.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No